- Poster discussion presentation
- Open Access
PD37 - Allergic disease may confer some protection against acute limphoblastic leukemia?
© Joacilda et al; licensee BioMed Central Ltd. 2014
- Published: 28 February 2014
- Atopic Dermatitis
- Allergic Rhinitis
- Allergic Disease
- Preceding History
Acute lymphoid leukemia is the most common pediatric cancer. Several factors may be found associated with leukemic state and previous allergic disease needs to be evaluated.
To investigate a possible association between preceding history of allergy disease and high Total IgE levels with Acute Lymphoid Leukemia in children and adolescents.
A hospital-based case-control study in the northeast region of Brazil. The population included 60 patients diagnosed with non-T acute lymphoid leukemia by means of bone marrow myelogram and immunophenotyping and 120 controls selected proportionally for age and gender. Data collection employed a structured questionnaire to determine prior history of allergies, as well as total IgE serum tests and clinical evaluations.
The results show that both total IgE serum levels and preceding history of asthma have a significant and inverse risk association with acute lymphoid leukemia.
In the unadjusted model, the exposure variables with a p-value < 0.20 were: asthma, high IgE levels, concomitant allergic diseases, atopic dermatitis, allergic rhinitis and urticaria. The inverse relation to both asthma and IgE serum levels continued to be significant in the adjusted model, showing significant p-value 0.044 and OR (CI 95%) of 0.14 (0.02 – 0.95); and p-value 0.001 and OR (CI 95%) of 0.10 (0.02 – 0.41), respectively.
High levels of total IgE, especially related to asthma, appear to contribute to alterations in the immune system, which may activate Th2-mediated pathways and this fact might confer some protective role against acute lymphoid leukemia.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.